Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 54.30
+0.40 (0.74%)
At close: Feb 11, 2026
Qing Song Health Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,081 | 982.56 | 868.66 | 636.69 | 357.54 | 240.24 | |
Revenue Growth (YoY) | 12.56% | 13.11% | 36.44% | 78.08% | 48.83% | 92.97% |
Cost of Revenue | 945.53 | 858.74 | 753.65 | 571.12 | 330.73 | 185.13 |
Gross Profit | 135.81 | 123.82 | 115.02 | 65.57 | 26.81 | 55.11 |
Selling, General & Admin | 88.73 | 79.7 | 61.11 | 51.66 | 31.54 | 22.72 |
Research & Development | - | - | - | - | - | 3.18 |
Other Operating Expenses | -0.16 | 0.01 | 0.08 | -0.41 | -0.72 | 0.33 |
Operating Expenses | 88.7 | 79.75 | 61.5 | 51.25 | 30.79 | 26.26 |
Operating Income | 47.11 | 44.07 | 53.52 | 14.32 | -3.98 | 28.85 |
Interest Expense | -24.65 | -23.1 | -17.64 | -14 | -11.3 | -11.21 |
Interest & Investment Income | 6.29 | 4.5 | 3.16 | 0.8 | 0.59 | 0.67 |
Earnings From Equity Investments | - | - | - | - | -0.16 | -0.23 |
Other Non Operating Income (Expenses) | 30.52 | 26.28 | 37.37 | 26.5 | 12.99 | 3.24 |
EBT Excluding Unusual Items | 59.27 | 51.75 | 76.42 | 27.61 | -1.87 | 21.33 |
Gain (Loss) on Sale of Investments | 17.3 | -0.48 | 3.69 | -1.05 | 0.04 | - |
Gain (Loss) on Sale of Assets | -0.45 | -0.61 | -0.97 | -0.29 | 0.01 | 0.1 |
Other Unusual Items | - | - | - | 1.22 | 1.46 | 1.03 |
Pretax Income | 76.13 | 50.66 | 79.14 | 27.5 | -0.36 | 22.46 |
Income Tax Expense | 9.68 | 9.96 | 20.31 | 8.98 | -0.58 | 6.44 |
Earnings From Continuing Operations | 66.44 | 40.7 | 58.83 | 18.52 | 0.22 | 16.01 |
Minority Interest in Earnings | -1.15 | -0.15 | 0.57 | 4.81 | -2.18 | -0.17 |
Net Income | 65.29 | 40.55 | 59.4 | 23.33 | -1.97 | 15.84 |
Net Income to Common | 65.29 | 40.55 | 59.4 | 23.33 | -1.97 | 15.84 |
Net Income Growth | 33.24% | -31.73% | 154.61% | - | - | 23.73% |
Shares Outstanding (Basic) | 64 | 60 | 60 | 60 | 60 | 52 |
Shares Outstanding (Diluted) | 64 | 60 | 60 | 60 | 60 | 52 |
Shares Change (YoY) | 7.29% | -0.01% | 0.01% | 0.01% | 15.91% | 44.86% |
EPS (Basic) | 1.01 | 0.68 | 0.99 | 0.39 | -0.03 | 0.31 |
EPS (Diluted) | 1.01 | 0.68 | 0.99 | 0.39 | -0.04 | 0.31 |
EPS Growth | 24.19% | -31.73% | 156.24% | - | - | -14.33% |
Free Cash Flow | 53.56 | 104.83 | -22.26 | 34.85 | 13.83 | -60.18 |
Free Cash Flow Per Share | 0.83 | 1.75 | -0.37 | 0.58 | 0.23 | -1.16 |
Dividend Per Share | 0.600 | 0.480 | 0.083 | - | - | - |
Dividend Growth | 625.51% | 480.41% | - | - | - | - |
Gross Margin | 12.56% | 12.60% | 13.24% | 10.30% | 7.50% | 22.94% |
Operating Margin | 4.36% | 4.49% | 6.16% | 2.25% | -1.11% | 12.01% |
Profit Margin | 6.04% | 4.13% | 6.84% | 3.66% | -0.55% | 6.59% |
Free Cash Flow Margin | 4.95% | 10.67% | -2.56% | 5.47% | 3.87% | -25.05% |
EBITDA | 115.66 | 108.66 | 109.43 | 67.77 | 38.37 | 47.81 |
EBITDA Margin | 10.70% | 11.06% | 12.60% | 10.64% | 10.73% | 19.90% |
D&A For EBITDA | 68.55 | 64.59 | 55.91 | 53.45 | 42.35 | 18.95 |
EBIT | 47.11 | 44.07 | 53.52 | 14.32 | -3.98 | 28.85 |
EBIT Margin | 4.36% | 4.49% | 6.16% | 2.25% | -1.11% | 12.01% |
Effective Tax Rate | 12.72% | 19.66% | 25.66% | 32.65% | - | 28.69% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.